Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 61Gastrointestinal 20Genitourinary 13Thoracic 12Plasma cell 9Lymphoid 7Head & Neck 7CNS 5Tumor-Agnostic 3Other 3Gynecologic 3Other hematologic neoplasm 2Sarcoma 1NET 1Myeloid 1Endocrine 1Dermatologic 1Classical hematology 1

Conditions

Sarcoma 1Febrile Neutropenia 1Cross Infection 1

Interventions

Radiotherapy 215Cyclophosphamide 210Doxorubicin 207Temozolomide 181Ifosfamide 121Filgrastim 111Etoposide 101Imatinib Mesylate 99Vincristine 92Gemcitabine 89Bevacizumab 83Irinotecan 79Magnetic Resonance Spectroscopy 78pembrolizumab 75Radiation 66Carboplatin 65pazopanib 60Methotrexate 60Nivolumab 58Cisplatin 58fludarabine phosphate 56Peripheral Blood Stem Cell Transplantation 56Specimen Handling 53Docetaxel 50Busulfan 48Trabectedin 47Biopsy 47Melphalan 46Surgical Procedures, Operative 44Paclitaxel 44

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Acupuncture Therapy × Sarcoma × Clear all
NCT06500715 2026-04-29

Acupuncture as add-on to G-CSF for Febrile Neutropenia-related Hospitalization in Doxorubicin-treated Patients With Sarcoma

Shaare Zedek Medical Center

Phase NA Not yet recruiting
60 enrolled
Classical hematologySarcoma

Cross Infection, Sarcoma, Febrile Neutropenia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡